Tower Research Capital LLC TRC purchased a new position in 111, Inc. (NASDAQ:YI – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 18,558 shares of the company’s stock, valued at approximately $29,000.
111 Price Performance
Shares of YI traded up $0.03 during trading hours on Friday, hitting $1.15. The stock had a trading volume of 41,834 shares, compared to its average volume of 33,455. The firm has a market capitalization of $96.04 million, a PE ratio of -1.74 and a beta of 0.36. 111, Inc. has a 12 month low of $0.97 and a 12 month high of $3.36. The stock has a fifty day moving average price of $1.20 and a 200 day moving average price of $1.57.
111 (NASDAQ:YI – Get Free Report) last posted its quarterly earnings data on Thursday, March 21st. The company reported ($0.34) earnings per share (EPS) for the quarter. The company had revenue of $578.69 million for the quarter.
111 Profile
111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.
Featured Stories
- Five stocks we like better than 111
- Why Invest in High-Yield Dividend Stocks?
- MarketBeat Week in Review – 4/29 – 5/3
- Why Invest in 5G? How to Invest in 5G Stocks
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What Is WallStreetBets and What Stocks Are They Targeting?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.